Enjoy complimentary customisation on priority with our Enterprise License!
The intrauterine contraceptive devices (IUD) market is estimated to grow at a CAGR of 3.98% between 2022 and 2027. The size of the market is forecast to increase by USD 965.49 million. This report covers several market vendors, including Abbie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc.. The growth of the market depends on several factors, including the increasing rate of unintended pregnancies and unwanted abortions, the initiatives by government and non-profit organizations, and the high growth of e-commerce platforms.
To learn more about this report, Download Report Sample
Technavio categorizes the global intrauterine contraceptive devices (IUD) market as a part of the global healthcare equipment market. The parent global healthcare equipment market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
Abbvie - The company offers intrauterine contraceptive devices such as the LILETTA (levonorgestrel-releasing) intrauterine contraceptive.
The market share growth by the hormonal intrauterine device segment will be significant during the forecast period. Hormonal intrauterine devices contain the hormone progestin, which inhibits ovulation by thinning the uterus lining and thickening the cervical mucus that blocks the sperm from reaching the egg, thereby preventing fertilization.
Get a glance at the market contribution of various segments Request a PDF Sample
The Hormonal intrauterine device segment showed a gradual increase in the market share of USD 3037.39 million in 2017 and continue to grow by 2021. Hormonal intrauterine devices decrease the risk of pelvic inflammatory disease (PID) and tubal pregnancies and help in treating symptoms such as polycystic ovary syndrome (PCOS) and endometriosis. Hormonal intrauterine devices are more effective in preventing pregnancies when compared with other contraception devices. They are superior to copper intrauterine devices and pose fewer complications and risks. Furthermore, our report provides a brief analysis of the historical and forecast market share and their segments along with the reasons for growth from 2017 to 2027.
For more insights on the market share of various regions Request PDF Sample now!
North America is projected to contribute 33% of market growth by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The US leads the intrauterine contraceptive devices (IUD) market in North America. The presence of local market players, supportive government initiatives, high awareness, and technological innovations such as postpartum and reusable IUDs drive market growth in the US.
The increasing number of unplanned pregnancies and unwanted abortions is notably driving the IUD market growth, although factors such as the adverse effects of IUDs may impede the market growth. Our researchers analyzed the data with 2022 as the base year and the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Intrauterine Contraceptive Devices (IUD) Market Driver
Significant Intrauterine Contraceptive Devices (IUD) Market Trend
Major Intrauterine Contraceptive Devices (IUD) Market Challenge
Key Intrauterine Contraceptive Devices (IUD) Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Intrauterine Contraceptive Devices (IUD) Market Customer Landscape
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology clinics, and Others), and Geography (North America, Europe, APAC, and Rest of World (ROW)).
Intrauterine Contraceptive Devices (IUD) Market Scope |
|
Report Coverage |
Details |
Page number |
149 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.98% |
Market growth 2023-2027 |
USD 965.49 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
3.68 |
Regional analysis |
North America, Europe, APAC, and Rest of World (ROW) |
Performing market contribution |
North America at 33% |
Key countries |
US, China, Japan, Germany, and France |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Drivers, Challenges, and Trends
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.